Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02774161 · ClinicalTrials.gov registry record · NA

B-mode Ultrasound Imaging in Detecting Early Liver Cancer

A NA study, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
45
Enrollment target

NCT02774161: Completed NA study, sponsored by Stanford University.

NCT02774161 is a NA study that has completed, run by Stanford University. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02774161, a NA study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
45 participants
Enrollment target

Study Summary

This pilot trial studies how well B-mode ultrasound imaging works in detecting liver cancer that is early in its growth and may not have spread to other parts of the body. Diagnostic procedures, such as B-mode ultrasound imaging, may help find and diagnose liver cancer and find out how far the disease has spread.

Interventions

  • OTHER Ultrasound Tomography

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2016-05
Est. Completion 2017-06-19
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT02774161

The ClinicalTrials.gov registry entry for NCT02774161 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Ultrasound Tomography is the first listed.

NCT02774161 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02774161 about?

NCT02774161 is a clinical study titled "B-mode Ultrasound Imaging in Detecting Early Liver Cancer". This pilot trial studies how well B-mode ultrasound imaging works in detecting liver cancer that is early in its growth and may not have spread to other parts of the body. Diagnostic procedures, such as B-mode ultrasound imaging, may help find and diagnose liver cancer and find out how far the disea...

What is the current status of trial NCT02774161?

This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2016-05. Estimated completion is 2017-06-19.

What interventions are being tested in trial NCT02774161?

The interventions under investigation include: Ultrasound Tomography (OTHER).

Who is sponsoring clinical trial NCT02774161?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.